Tags

Type your tag names separated by a space and hit enter

Influenza and respiratory syncytial virus in the elderly.
Expert Rev Vaccines. 2008 Mar; 7(2):249-58.ER

Abstract

Respiratory infections are one of the leading causes of morbidity and mortality worldwide: influenza and respiratory syncytial virus (RSV) are the predominant pathogens responsible. Annual vaccination and the use of antiviral drugs provides both protection and treatment against influenza, particularly protecting those patients most at risk, including the elderly and individuals with chronic comorbidities. Currently, there are extremely limited options in the protection against RSV infection, making those at-risk patients vulnerable to serious disease, complications and death. This review focuses on recent trends in respiratory illness in the elderly, particularly focusing on the burden of influenza and RSV on hospitalizations and mortality. We discuss the potential benefit of influenza vaccination on these outcomes, including the recent controversial debate over the effectiveness of influenza vaccination.

Links

Publisher Full Text
Aggregator Full Text

Authors+Show Affiliations

Elliot AJ
Birmingham Research Unit of the Royal College of General Practitioners, Lordswood House, 54 Lordswood Road, Harborne, Birmingham B17 9DB, UK. aelliot@rcgpbhamresunit.nhs.uk
Fleming DM
No affiliation info available

MeSH

AgedFemaleHospitalizationHumansIncidenceInfluenza A virusInfluenza VaccinesInfluenza, HumanMaleRespiratory Syncytial Virus InfectionsRespiratory Syncytial VirusesRespiratory Tract InfectionsTreatment Outcome

Pub Type(s)

Journal Article
Review

Language

eng

PubMed ID

18324893

Citation

Elliot, Alex J., and Douglas M. Fleming. "Influenza and Respiratory Syncytial Virus in the Elderly." Expert Review of Vaccines, vol. 7, no. 2, 2008, pp. 249-58.
Elliot AJ, Fleming DM. Influenza and respiratory syncytial virus in the elderly. Expert Rev Vaccines. 2008;7(2):249-58.
Elliot, A. J., & Fleming, D. M. (2008). Influenza and respiratory syncytial virus in the elderly. Expert Review of Vaccines, 7(2), 249-58. https://doi.org/10.1586/14760584.7.2.249
Elliot AJ, Fleming DM. Influenza and Respiratory Syncytial Virus in the Elderly. Expert Rev Vaccines. 2008;7(2):249-58. PubMed PMID: 18324893.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Influenza and respiratory syncytial virus in the elderly. AU - Elliot,Alex J, AU - Fleming,Douglas M, PY - 2008/3/8/pubmed PY - 2008/4/1/medline PY - 2008/3/8/entrez SP - 249 EP - 58 JF - Expert review of vaccines JO - Expert Rev Vaccines VL - 7 IS - 2 N2 - Respiratory infections are one of the leading causes of morbidity and mortality worldwide: influenza and respiratory syncytial virus (RSV) are the predominant pathogens responsible. Annual vaccination and the use of antiviral drugs provides both protection and treatment against influenza, particularly protecting those patients most at risk, including the elderly and individuals with chronic comorbidities. Currently, there are extremely limited options in the protection against RSV infection, making those at-risk patients vulnerable to serious disease, complications and death. This review focuses on recent trends in respiratory illness in the elderly, particularly focusing on the burden of influenza and RSV on hospitalizations and mortality. We discuss the potential benefit of influenza vaccination on these outcomes, including the recent controversial debate over the effectiveness of influenza vaccination. SN - 1744-8395 UR - https://www.unboundmedicine.com/medline/citation/18324893/Influenza_and_respiratory_syncytial_virus_in_the_elderly_ L2 - https://www.tandfonline.com/doi/full/10.1586/14760584.7.2.249 DB - PRIME DP - Unbound Medicine ER -